Mojirade James - 06 Mar 2024 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, General Counsel
Signature
/s/ John Hurley, as attorney-in-fact for Mojirade James
Issuer symbol
AVNS
Transactions as of
06 Mar 2024
Net transactions value
+$550,433
Form type
4
Filing time
07 Mar 2024, 17:01:52 UTC
Previous filing
06 Mar 2024
Next filing
23 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $587,502 +30,695 +73% $19.14 72,948 06 Mar 2024 Direct F1
transaction AVNS Common Stock Tax liability $37,069 -1,951 -2.7% $19.00 70,997 06 Mar 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 6, 2025, 1/3 on March 6, 2026 and 1/3 on March 6, 2027.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of TRSUs awarded to the Reporting Person on March 6, 2023, of which 1/3 vested on March 6, 2024, 1/3 will vest on March 6, 2025 and the remaining 1/3 will vest on March 6, 2026.